yingweiwo

BDZ-g

Cat No.:V12349 Purity: ≥98%
BDZ-g is a potent and specific AMPA receptor blocker (antagonist).
BDZ-g
BDZ-g Chemical Structure CAS No.: 732278-52-3
Product category: New1
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
1mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Product Description
BDZ-g is a potent and specific AMPA receptor blocker (antagonist). BDZ-g may be used for studying a variety of neurological diseases involving excessive activity of AMPA receptors.
Biological Activity I Assay Protocols (From Reference)
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C21H21N5O2S
Molecular Weight
407.488742589951
Exact Mass
407.141
CAS #
732278-52-3
PubChem CID
10250827
Appearance
White to yellow solid powder
LogP
4.6
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Rotatable Bond Count
2
Heavy Atom Count
29
Complexity
636
Defined Atom Stereocenter Count
1
SMILES
S1C(C)=NN=C1N1[C@@H](C)CC2C=C3C(=CC=2C(C2C=CC(=C(C)C=2)N)=N1)OCO3
InChi Key
DBDUGNPURSLMPS-GFCCVEGCSA-N
InChi Code
InChI=1S/C21H21N5O2S/c1-11-6-14(4-5-17(11)22)20-16-9-19-18(27-10-28-19)8-15(16)7-12(2)26(25-20)21-24-23-13(3)29-21/h4-6,8-9,12H,7,10,22H2,1-3H3/t12-/m1/s1
Chemical Name
2-methyl-4-[(8R)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl]aniline
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution 50 μL Tween 80 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO 400 μLPEG300 50 μL Tween 80 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO 100 μLPEG300 200 μL castor oil 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol 100 μL Cremophor 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH 400 μLPEG300 50 μL Tween 80 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.4540 mL 12.2702 mL 24.5405 mL
5 mM 0.4908 mL 2.4540 mL 4.9081 mL
10 mM 0.2454 mL 1.2270 mL 2.4540 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • (a) A pair of representative whole-cell current response of GluA2Qflip receptors, expressed in an HEK-293 cell, to 3 mM glutamate in the absence (left) and presence (right) of 0.5 μM BDZ-g. The whole-cell recording was at −60 mV, pH 7.4, and 22 °C. The inhibitory effects of the 2,3-BDZs are shown on the AMPA (b), kainate (c), and NMDA receptors (d). An inhibitory effect of a compound on any of these receptors is shown as the percentage of the current response in the presence and absence of that compound (AI/A). Each point is an average of at least three measurements from three cells. Specially, 50 μM glutamate was used for assaying with the closed-channel state of GluA1flip and kainate receptors, and 100 μM for the others; 2 mM glutamate was used for assaying with the open-channel state of GluA1flip and the kainate receptors, and 3 mM glutamate for all others receptors. The NMDA receptors were tested only with 50 μM glutamate and 100 μM glycine (as in panel d). All the compounds were tested at 20 μM except BDZ-g and BDZ-h on AMPA receptors. Because of their strong potency, we used 1 μM for both compounds with all four AMPA receptors. However, we calibrated the AI/A to a 20 μM percentage for comparison with all other compounds in the same plot.[1].Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem Neurosci. 2014;5(2):138-147.
  • (a) Effect of BDZ-g on the whole-cell current amplitude of GluA2Qflip receptors obtained from the solution flow technique. A KI of 0.5 ± 0.1 μM was determined for the closed-channel state (100 μM glutamate, ●), whereas a Inline graphic of 0.7 ± 0.1 μM was obtained for the open-channel state (3 mM glutamate, ○). (b) Effect of BDZ-h on the whole-cell current amplitude of GluA2Qflip receptors obtained from the same technique. A KI of 0.5 ± 0.1 μM was determined for the closed-channel state (100 μM glutamate, ●), whereas a Inline graphic of 0.6 ± 0.1 μM was obtained for the open-channel state (3 mM glutamate, ○). All the inhibition constants were determined using eq 1. In both (a) and (b), each data point is the average of at least three separate measurements from different cells.[1].Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem Neurosci. 2014;5(2):138-147.
  • (a) Double-inhibitor experiment for GYKI 52466 and BDZ-g with the GluA2Qflip receptor (note that 100 μM glutamate was used for the assay, which reflected the closed-channel state of GluA2Qflip). The concentration of GYKI 52466 was kept at 20 μM, while that of BDZ-g varied from 0.5 to 3 μM. The apparent double-inhibition constant, KI′, was determined to be 0.5 ± 0.1 μM (filled circles, ●), as compared with KI of 0.5 ± 0.1 μM for BDZ-g alone (open circles, ○). The dashed line is the simulation of the A/AI plot on the assumption that the two inhibitors bound to two different sites with a double-inhibition constant of ∼0.3 μM (when GYKI 52466 was kept at 20 μM). The dashed line was generated using eq 3. (b) Double-inhibitor experiment for GYKI 52466 and BDZ-h with the GluA2Qflip receptor. The concentration of GYKI 52466 was kept at 20 μM, while that of BDZ-h varied from 0.2 to 1.5 μM. The glutamate concentration was μM 100, which corresponded to the closed-channel conformation. The apparent double-inhibition constant, KI′, was determined to be 0.5 ± 0.1 μM (filled circles, ●), as compared with KI of 0.5 ± 0.1 μM for BDZ-h alone (open circles, ○). By the use of eq 3, the dashed line is generated that simulates the A/AI plot based on the assumption that the two inhibitors bound to two different sites with a double-inhibition constant of ∼0.3 μM (when GYKI 52466 was kept at 20 μM). (c) Double-inhibitor experiment for BDZ-g and BDZ-h with GluA2Qflip. The concentration of BDZ-g was fixed at 0.5 μM, while that of BDZ-h varied from 0.1 to 1.5 μM. The apparent double-inhibition constant, KI′, was determined to be 0.5 ± 0.1 μM (filled circles, ●), as compared with KI of 0.5 ± 0.1 μM for BDZ-h alone (open circles, ○). As in (b), the glutamate concentration was at 100 μM. The dashed line is the simulation of the A/AI plot based on the assumption that the two inhibitors bound to two different sites with a double-inhibition constant of ∼0.3 μM (when BDZ-g was kept at 0.5 μM). (d) A pair of representative whole-cell current response of the GluA2Qflip receptors to 100 μM glutamate in the absence (left) and presence (right) of 20 μM 2,5-dimethyl-1,3,4-thiadiazole.[1].Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem Neurosci. 2014;5(2):138-147.
Contact Us